Related Experiment Video
Updated: Jan 2, 2026

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
Death by Opioids: Are there non-addictive scientific solutions?
B William Downs1, Kenneth Blum1,2,3,4,5,6, David Baron2
1Department of Nutrigenomic Research, Victory Nutrition International, Inc., Lederach, PA, USA.
Abstract:
In the face of the current Opioid crisis in America killing close to 800,000 people since 2004, we are proposing a novel approach to assist in at least attenuating these unwanted premature deaths. While we applaud the wonderful efforts of our governmental institutes and professional societies (NIDA, NIAAA, ASAM, ABAM ) in their extraordinary efforts in combating this continued dilemma, the current approach is failing, and other alternative approaches should at least be tested. These truths present a serious ethical dilemma to scientists, clinicians and counselors in the Reward Deficiency Syndrome (RDS) treatment community. It is important to realize that the current DSM-5 does not actually accurately display the natural brain reward process. The human brain has not been designed to carve out specific drugs like opioids, alcohol, nicotine, cocaine, benzodiazepines or cannabis and process addictions such as gambling as distinct endophenotypes. This is true in spite of natural ligands for cannabinoids, endorphins, or even benzodiazepines. The most accurate endophenotype is indeed reward dysfunction (e.g hypodopaminergic or hyperdopaminergic). With this mind, we are hereby proposing that the current Medication Assisted Treatment (i.e. 'MAT') expands to needed individuals as an initial "Band-Aid" to reduce harm avoidance, with the long-term goal of prophylaxis. So, to be clear, there may be other promising modalities other than MAT such as repetitive transcranial magnetic stimulation (rTMS), exercise and even new medications with positive allosteric modulators of GABA-A receptors, as well as the highly researched Genetic Addiction Risk Score (GARS) coupled with precision KB220Z. This will induce "dopamine homeostasis" to effectively rebalance and restore healthier brain function by promoting the cross talk between various brain regions (e.g. Nucleus accumbens, cingulate gyrus, hippocampus etc.) resulting in dopamine homeostasis. Our laudable goal is to not only save lives, but to redeem joy and improve the quality of life in the recovery community through scientifically sound natural non-addicting alternatives.
Insights
The current opioid crisis demands new addiction treatment strategies beyond Medication Assisted Treatment (MAT). We propose focusing on reward dysfunction and dopamine homeostasis for long-term recovery and improved quality of life.
Area of Science:
- Neuroscience
- Addiction Medicine
- Psychiatry
Background:
- The ongoing opioid crisis has caused nearly 800,000 deaths since 2004, indicating current treatment approaches are insufficient.
- The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) does not accurately represent the brain's reward process, failing to identify addiction as a core reward dysfunction.
- Reward Deficiency Syndrome (RDS) is proposed as a more accurate endophenotype for addiction, characterized by hypodopaminergic or hyperdopaminergic states.
Purpose of the Study:
- To propose a novel approach to addiction treatment focusing on restoring dopamine homeostasis.
- To advocate for expanding treatment beyond current Medication Assisted Treatment (MAT) to include alternative modalities.
- To address the ethical dilemma faced by clinicians and scientists in the RDS community regarding effective addiction treatment.
Main Methods:
- Critiquing the current DSM-5 classification of addiction disorders.
- Proposing Reward Deficiency Syndrome (RDS) as the primary endophenotype for addiction.
- Suggesting a multi-modal treatment approach including MAT as an initial harm-reduction strategy, followed by long-term prophylaxis.
- Highlighting alternative therapies such as repetitive transcranial magnetic stimulation (rTMS), exercise, novel GABA-A receptor modulators, and the Genetic Addiction Risk Score (GARS) with KB220Z.
Main Results:
- The proposed approach aims to induce "dopamine homeostasis" by rebalancing brain function and enhancing neural communication.
- This rebalancing is expected to restore healthier brain function, particularly in regions crucial for reward processing like the nucleus accumbens, cingulate gyrus, and hippocampus.
- The ultimate goal is to achieve a more scientifically sound and effective treatment for addiction.
Conclusions:
- Current addiction treatments, including MAT, are failing to adequately address the opioid crisis.
- Reward dysfunction, not specific substances or behaviors, is the most accurate endophenotype for addiction.
- A comprehensive, multi-modal treatment strategy targeting dopamine homeostasis offers a promising path toward long-term recovery and improved quality of life.
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Depressants
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...